期刊文献+

某军队医院2014-2017年医院感染现患率调查结果分析 被引量:3

Survey on prevalence rate of nosocomial infection in a station troops hospital from 2014 to 2017
原文传递
导出
摘要 目的了解住院患者医院感染现状,为防控提供参考依据。方法采用现患率调查方法,连续4年对某军队三级甲等医院医院感染现状进行调查并分析相关数据。结果共调查住院患者3 498例,2014-2017年医院感染现患率分别为1.54%、1.35%、1.79%和2.13%,内科系统明显高于外科系统;患病率较高科室为急诊重症病房、重症医学科。感染部位以肺感染居首位,其次是泌尿道感染。医院感染病原菌以革兰阴性菌为主,占52.8%;临床分离病原菌36株,多重耐药菌株检出率为52.8%;住院患者抗菌药物使用率为50%。结论该院医院感染现患率在规范要求范围内,抗菌药物使用率与属地控制目标存在差距。 Objective To know the present situation of the nosocomial infection,and to provide reference for prevention and control. Methods A cross-sectional study was used to survey and analyze prevalence rate of nosocomial infection of inpatients in a troops hospital for 4 continuous years. Results A total of 3 498 patients were investigated. From 2014 to2017,The point prevalence rate was 1. 54%,1. 35%,2. 13%,1. 79%,respectively. And the rate was higher in internal medicine department than it was in surgery department. Emergency intensive care unit( EICU) and intensive care unit( ICU) had the higher infection rate. The first important site of infection was lung infection,second was urinary tract infection. Gram-negative bacteria was the chief pathogenic microorganisms and its constituent ratio was 52. 8%. 36 strains of clinical pathogenic bacteria were isolated,the detection rate of MDRS was 52. 8%. The utilization rate of antibiotics was about 50%. Conclusion The prevalence rate in this hospital is within the standard requirement,there is a gap between the use of antimicrobial agents and their territoriality control standard.
作者 剧志英 王涛 曾艳 宋斐翡 JU Zhi - ying;WANG Tao;ZENG Yan;SONG Fei - fei(The 254th Hospital of PLA,Tianjin 300142,China)
出处 《中国消毒学杂志》 北大核心 2017年第12期1138-1140,共3页 Chinese Journal of Disinfection
关键词 医院感染 现患率 抗菌药物 nosocomial infection prevalence rate antibiotics
  • 相关文献

参考文献2

二级参考文献27

  • 1Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 3Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 4Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.
  • 5Chen S. Hu F. Zhang X. et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatrnentj]]. J Clin Microbiol , 2011. 49( 11): 4022- 4023.
  • 6van Duin D. Kaye KS. Neuner EA. et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes[J]. Diagn Microbiol Infect Dis. 2013. 75(2): l1S-120.
  • 7Daikos GL. Tsaousi S. Tzouvelekis LS. et al. Carbapenemaseproducing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems [J]. Antimicrob Agents Chernother , 2014.58 (4): 2322-2328.
  • 8Tascini C. Tagliaferri E. Giani T. et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPCproducing Klebsiella pneumoniae [J]. Antimicrob Agents Chernother , 2013. 57 (8): 3990-3993.
  • 9Pulcini C. Bush K. Craig WA. et al. Forgotten Antibiotics: an Inventory in Europe. the United States. Canada. and Australia[J]. Clin Infect Dis. 2012. 54(2): 268-274.
  • 10Falagas ME. Giannopoulou KP. Kokolakis GN. et al. Fosfomycin , use beyond urinary tract and gastrointestinal infections [J]. Clin Infect Dis. 2008. 46(7): 1069-1077.

共引文献622

同被引文献30

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部